Genetic variants inCYP(-1A2,-2C9,-2C19,-3A4and-3A5),VKORC1andABCB1genes in a black South African population: a window into diversity

Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population

(2011) Cathrine Mitchell et al.   PHARMACOGENOMICS

Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium

(2011) Pamala A. Jacobson et al.   TRANSPLANTATION

Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa Population

(2010) Galen E. B. Wright et al.   ANNALS OF HUMAN GENETICS

Population Pharmacokinetic-Pharmacogenetic Study of Nevirapine in HIV-Infected Cambodian Patients

(2010) M. Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

The Structure and Functions of P-Glycoprotein

(2010) Y. Li et al.   CURRENT MEDICINAL CHEMISTRY

Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction

(2010) Marianne K. Kringen et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements

(2010) Kendra A Ross et al.   JOURNAL OF HUMAN GENETICS

Integrating common and rare genetic variation in diverse human populations

(2010)   NATURE

A map of human genome variation from population-scale sequencing

(2010) Richard M. Durbin et al.   NATURE

CYP1A2 is more variable than previously thought: a genomic biography of the gene behind the human drug-metabolizing enzyme

(2010) Sarah L. Browning et al.   Pharmacogenetics and Genomics

Characterization of the genetic profile ofCYP2C19in two South African populations

(2010) Britt I Drögemöller et al.   PHARMACOGENOMICS

Applying the genome to national drug formulary policy in the developing world

(2010) Mary W Roederer et al.   PHARMACOGENOMICS

Genetic Variations in ABCB1 and CYP3A5 as well as Sex Influence Quinine Disposition Among Ugandans

(2010) Jackson K Mukonzo et al.   THERAPEUTIC DRUG MONITORING

Pharmacogenetics: from discovery to patient care

(2009) Jaekyu Shin et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Molecular Population Genetics of Human CYP3A Locus: Signatures of Positive Selection and Implications for Evolutionary Environmental Medicine

(2009) Xiaoping Chen et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Host Genetic Influences on Highly Active Antiretroviral Therapy Efficacy and AIDS-Free Survival

(2009) Sher L Hendrickson et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

A pharmacogenetic study of CD4 recovery in response to HIV antiretroviral therapy in two South African population groups

(2009) John Parathyras et al.   JOURNAL OF HUMAN GENETICS

Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population

(2009) Arzu Gunes et al.   PHARMACOGENOMICS

Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome

(2009) B Laika et al.   PHARMACOGENOMICS JOURNAL

Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study

(2008) Ushma Mehta et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients

(2008) Petra Bohanec Grabar et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Substrate-Dependent Effects of Human ABCB1 Coding Polymorphisms

(2008) J. M. Gow et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group

(2008) C M Bromley et al.   PHARMACOGENOMICS JOURNAL